These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 1974099
1. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters]. Stangl K, Baumann G, Weil J, Gerzer R, Kerscher M, Blömer H. Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099 [Abstract] [Full Text] [Related]
2. Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure. Stangl K, Baumann G, Gerzer R, Weil J. Eur Heart J; 1991 Aug; 12(8):917-23. PubMed ID: 1655438 [Abstract] [Full Text] [Related]
3. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A. G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [Abstract] [Full Text] [Related]
4. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot. Hayabuchi Y, Matsuoka S, Kuroda Y. Pediatr Cardiol; 1999 Aug; 20(5):343-50. PubMed ID: 10441688 [Abstract] [Full Text] [Related]
5. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion]. Lechleitner P, Genser N, Hauptlorenz S, Putensen C, Mitterschiffthaler G, Artner-Dworzak E, Puschendorf B, Dienstl F. Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054 [Abstract] [Full Text] [Related]
6. Humoral and hemodynamic responses after left ventricular assist device implantation and heart transplantation. Wagner FD, Buz S, Zais H, Stasch JP, Hetzer R, Hocher B. Exp Biol Med (Maywood); 2006 Jun; 231(6):861-4. PubMed ID: 16741013 [Abstract] [Full Text] [Related]
7. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A. Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [Abstract] [Full Text] [Related]
8. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats. Pesonen A, Leppäluoto J, Ruskoaho H. J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537 [Abstract] [Full Text] [Related]
12. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure]. Indolfi C, Piscione F, Volpe M, Lembo G, De Campora P, Russolillo E, Ambrosini V, Condorelli M, Chiariello M. Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751 [Abstract] [Full Text] [Related]
13. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide. Weil J, Gerzer R, Strom T, Lang RE, Döhlemann C, Knorr D, Bidlingmaier F. Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478 [Abstract] [Full Text] [Related]
15. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T. Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065 [Abstract] [Full Text] [Related]
16. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD. Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Grabensee B. Adv Perit Dial; 1990 Oct 10; 6():211-9. PubMed ID: 1982811 [Abstract] [Full Text] [Related]